ETAILS Medanta, DLF To Launch 400-Bed Hospital In South Delhi

New Delhi : Global Health Limited will launch a 400-bed multi-super specialty hospital in Delhi in association with real estate developer DLF, the private healthcare provider said on Thursday.

The super speciality hospital is slated to provide cutting-edge medical and surgical interventions in over 20 super specialties, including Cardiac sciences, Neurosciences, Orthopaedics, Kidney, Liver, Lung and Heart Transplants, Gastroenterology, and Chest Surgery, the company said in a statement.

The facility will also have a Comprehensive Cancer Care unit, offering end-to-end oncology treatments under one roof. This new facility will strengthen Medanta’s presence in the National Capital Region of Delhi. Medanta will operate its Gurugram, Noida, and Delhi facilities in a seamless manner linking its existing 1,391-bed flagship hospital in Gurugram and its upcoming Noida facility (550 beds) to the new hospital in South Delhi.

“Our new hospital will bring the best of Medanta’s renowned clinical expertise and patient care closer to the people of Delhi. It will offer cutting-edge surgical treatments across specialties under one roof with the same patient quality safety standards that Medanta has come to be known for. It will also become a one-stop solution for all types of cancer treatments and will benefit a large swathe of patients not only in Delhi but across Uttar Pradesh, Haryana, Rajasthan, and other neighbouring states,” Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, said.

Both Medanta and DLF will hold equal 50% equity in the new company, which is set to inaugurate the upcoming hospital in Greater Kailash (GK), South Delhi. DLF will serve as a strategic investor, while Medanta will assume operational control of the hospital, as stated by Global Health Limited in a regulatory filing.

“The new hospital will strengthen the medical infrastructure in Delhi and further strengthen DLF’s deep commitment to improving the quality of life for NCR residents,” Rajiv Singh, Chairman of DLF Ltd said.

Related Posts

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

The Central Drugs Standard Control Organisation (CDSCO) found one spurious and 220 not of standard quality (NSQ) drug samples from a batch tested randomly as part of the August drug…

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

The action follows the department’s investigation into a large-scale unlicenced drug repacking and relabelling racket uncovered at a farmhouse in Bengaluru South district’s Bidadi on August 18. The Karnataka Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman